Glycomics/Glycobiology Market Size, Share, By Product Type (Enzymes, Instruments, Kits & Reagents, and Others), Application (Drug Discovery and Development, Diagnostics, and Others), End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs, and Others), and Region - Trends, Analysis, and Forecast till 2035

• Thermo Fisher Scientific Inc.
• New England Biolabs
• Promega Corporation
• Merck KGaA
• Waters Corporation
• Takara Bio Inc.
• Bio-Techne
• Agilent Technologies, Inc.
• Sumitomo Bakelite Co., Ltd.
• Bruker
• Pegasus Laboratories, Inc.
• Shimadzu Corporation
• Danaher
• RayBiotech, Inc.

Recent News:

• Griffith University’s Institute for Glycomics was supposed to launch an Australian-first centre dedicated to deciphering the cancer glycol-code, which was funded by Australian Cancer Research Foundation (ACRF), in August 2022. The ACRF International Centre for Cancer Glycomics would enable the Institute’s researchers to determine changes to the glycomics and its interactions with proteins and lipids in a number of cancers.
• BioGlyco, a leading provider of services and products in the field of glycobiology, announced the launch of its new-sub-brand, Marine Glycobiology, which offered a wide range of services and products tailored to meet the diverse needs of researchers and industries worldwide, in January 2025. Glycans originating from marine sources are different from terrestrial sources, thereby is an important resource for discovering new biomolecules for research and development.